Background: Diabetic nephropathy (DN) remains a leading cause of end-stage renal disease among patients with Type 2 diabetes mellitus (T2DM). Identifying clinical and metabolic predictors is crucial for early detection and intervention in resource-limited settings.
Objective: The object...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.